Ryan J Rebernick

5PUBLICATIONS
70CO-AUTHORS
Molecular targetsPredictive and prognostic markersInnate immunityGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 07, 2025
Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer.

Nofar Gumpert, Shira Sagie, Claudia Arnedo-Pac

|Aug 18, 2025
Divergent Clonal Evolution and Early Dissemination Promote Genetic Heterogeneity of Metastases in Castration-Resistant Prostate Cancer.

Noshad Hosseini, Rahul Mannan, Ryan J Rebernick

|Jun 26, 2025
Divergent FOXA1 mutations drive prostate tumorigenesis and therapy-resistant cellular plasticity.

Sanjana Eyunni, Rahul Mannan, Yuping Zhang

|Apr 22, 2024
Fmo5 plays a sex-specific role in goblet cell maturation and mucus barrier formation.

Megan L Schaller, Madeline M Sykes, Joy Mecano

|Jan 10, 2024
Comprehensive genetic study of the insulin resistance marker TG:HDL-C in the UK Biobank.

Antonino Oliveri, Ryan J Rebernick, Annapurna Kuppa

Pageof 1

Frequent Collaborators

2 joint publications

Rui Wang

2 joint publications

Marcin P Cieslik

2 joint publications

Rohit Mehra

2 joint publications

Xuhong Cao